Market Research Logo

Bulgaria Pharmaceuticals & Healthcare Q3 2018

Bulgaria Pharmaceuticals & Healthcare Q3 2018

BMI View:

The challenging nature of medicine reimbursement in Bulgaria is an impediment to the broader availability of drugs,limiting the investment prospects from multinational pharmaceutical firms. Additionally, as one of the poorest populations in the EU,patients are highly reliant on the subsidisation of medicine costs which extends beyond high-value drugs to more routineprescriptions.


BMI Industry View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Central And Eastern Europe Pharmaceuticals Risk/Reward Index
Bulgaria Pharmaceuticals & Healthcare Risk/Reward Index
Regulatory Development
Market Overview
Competitive Landscape
Company Profile
Sopharma
Demographic Forecast
Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report